Related Experiment Video
Updated: Jul 1, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Encapsulation of apigenin into β-cyclodextrin metal-organic frameworks with high embedment efficiency and stability
Yaqi Liu1, Chao Yuan1, Bo Cui1
1State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China; School of Food Science and Engineering, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China.
Researchers improved apigenin performance by encapsulating it in β-cyclodextrin metal-organic frameworks (BCDMOFs). This novel method enhanced apigenin stability and controlled its release, boosting application performance.
Area of Science:
- Materials Science
- Nanotechnology
- Pharmacology
Background:
- Apigenin, a natural flavonoid, has therapeutic potential but suffers from poor application performance.
- Developing effective delivery systems is crucial for enhancing apigenin's bioavailability and efficacy.
Purpose of the Study:
- To encapsulate apigenin within β-cyclodextrin metal-organic frameworks (BCDMOFs) to improve its application performance.
- To investigate the pH-dependent encapsulation efficiency and stability of apigenin within BCDMOFs.
Main Methods:
- Apigenin was encapsulated into BCDMOFs using an innovative pH-adjusted method.
- Characterization of the resulting composites was performed using scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, and thermogravimetric analysis.
- Storage stability and kinetic release studies were conducted.
Main Results:
- Encapsulation efficiency reached a maximum of 79.2% ± 1.2% at pH 12, demonstrating significant pH dependence.
- Characterization confirmed the formation of apigenin/BCDMOFs composites with facilitated pore exposure for high embedment.
- Apigenin stability increased by approximately 18% over 7 days compared to free apigenin, indicating enhanced degradation resistance.
Conclusions:
- BCDMOFs effectively encapsulate apigenin, enhancing its stability and controlling its release.
- The developed apigenin/BCDMOFs composites show improved application performance in vitro.
- This study presents a promising strategy for improving the delivery and efficacy of apigenin.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

